Brii Biosciences Valuation
| BRIBF Stock | USD 0.13 0.00 0.00% |
Brii Biosciences seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Brii Biosciences from analyzing the firm fundamentals such as Operating Margin of (10.33) %, return on equity of -5.34, and Shares Outstanding of 723.35 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Brii Biosciences' price fluctuation is very steady at this time. Calculation of the real value of Brii Biosciences is based on 3 months time horizon. Increasing Brii Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Brii pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Brii Biosciences Limited. Since Brii Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Brii Pink Sheet. However, Brii Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.13 | Real 0.11 | Hype 0.13 | Naive 0.13 |
The real value of Brii Pink Sheet, also known as its intrinsic value, is the underlying worth of Brii Biosciences Company, which is reflected in its stock price. It is based on Brii Biosciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Brii Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Brii Biosciences Limited helps investors to forecast how Brii pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Brii Biosciences more accurately as focusing exclusively on Brii Biosciences' fundamentals will not take into account other important factors: Brii Biosciences Total Value Analysis
Brii Biosciences Limited is currently forecasted to have takeover price of 305.78 M with market capitalization of 941.75 M, debt of 17.47 M, and cash on hands of 3.22 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Brii Biosciences fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
305.78 M | 941.75 M | 17.47 M | 3.22 B |
Brii Biosciences Asset Utilization
One of the ways to look at asset utilization of Brii is to check how much profit was generated for every dollar of assets it reports. Brii Biosciences Limited shows a negative utilization of assets of -0.19 percent, losing $0.001877 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Brii Biosciences Limited shows how discouraging it operates for each dollar spent on its assets.Brii Biosciences Ownership Allocation
Brii Biosciences holds a total of 723.35 Million outstanding shares. Over half of Brii Biosciences' outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Brii Biosciences Profitability Analysis
Net Loss for the year was (4.16 B) with profit before overhead, payroll, taxes, and interest of 92.54 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Brii Biosciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Brii Biosciences and how it compares across the competition.
About Brii Biosciences Valuation
The pink sheet valuation mechanism determines Brii Biosciences' current worth on a weekly basis. Our valuation model uses a comparative analysis of Brii Biosciences. We calculate exposure to Brii Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Brii Biosciences's related companies.Brii Biosciences Limited engages in the development of medicines for the treatment of infectious and central nervous system diseases. The company was incorporated in 2017 and is based in Beijing, China. Brii Bioscience is traded on OTC Exchange in the United States.
8 Steps to conduct Brii Biosciences' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Brii Biosciences' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Brii Biosciences' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Brii Biosciences' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Brii Biosciences' revenue streams: Identify Brii Biosciences' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Brii Biosciences' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Brii Biosciences' growth potential: Evaluate Brii Biosciences' management, business model, and growth potential.
- Determine Brii Biosciences' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Brii Biosciences' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Brii Biosciences Growth Indicators
Investing in growth stocks can be very risky. If the company such as Brii Biosciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 720.1 M | |
| Retained Earnings | -6 B |
Complementary Tools for Brii Pink Sheet analysis
When running Brii Biosciences' price analysis, check to measure Brii Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brii Biosciences is operating at the current time. Most of Brii Biosciences' value examination focuses on studying past and present price action to predict the probability of Brii Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brii Biosciences' price. Additionally, you may evaluate how the addition of Brii Biosciences to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |